NASOPHARYNGEAL CANCER

This adverse event was reported 262 times

These drugs are most commonly taken by patients reporting NASOPHARYNGEAL CANCER:

# Drug Count
0 METHOTREXATE SODIUM 22
1 INFLIXIMAB 21
2 METHOTREXATE 18
3 RANITIDINE 17
4 ETANERCEPT 14
5 ADALIMUMAB 12
6 RANITIDINE HYDROCHLORIDE 12
7 CISPLATIN 11
8 CYCLOPHOSPHAMIDE 10
9 CYCLOPHOSPHAMIDE FOR INJECTION 10
See all common drugs associated with NASOPHARYNGEAL CANCER